For research use only. Not for therapeutic Use.
FPA 124(Cat No.:I010652)is a potent and selective inhibitor of glycogen synthase kinase-3 beta (GSK-3β), an enzyme involved in various cellular processes such as inflammation, cell proliferation, and neurodegeneration. By inhibiting GSK-3β, FPA 124 has demonstrated neuroprotective effects, making it a valuable compound in research for neurodegenerative diseases like Alzheimer’s and Parkinson’s. It also exhibits anti-inflammatory properties, which may contribute to its potential therapeutic applications. FPA 124 is widely used in studies exploring the role of GSK-3β in disease pathogenesis and the development of novel therapeutic strategies.
Catalog Number | I010652 |
CAS Number | 902779-59-3 |
Synonyms | Dichloro[(2Z)-2-[(4-oxo-4H-1-benzopyran-3-yl)methylene]hydrazinecarbothioamide copper complex |
Molecular Formula | C11H9Cl2CuN3O2S |
Purity | ≥95% |
Target | Apoptosis |
Solubility | Soluble to 10 mM in DMSO and to 10 mM in ethanol |
Storage | Store at 4℃ |
IUPAC Name | dichlorocopper;[(Z)-(4-oxochromen-3-yl)methylideneamino]thiourea |
InChI | InChI=1S/C11H9N3O2S.2ClH.Cu/c12-11(17)14-13-5-7-6-16-9-4-2-1-3-8(9)10(7)15;;;/h1-6H,(H3,12,14,17);2*1H;/q;;;+2/p-2/b13-5-;;; |
InChIKey | HZRXQEVFXXQYFS-KHDHKOIVSA-L |
SMILES | C1=CC=C2C(=C1)C(=O)C(=CO2)/C=N\NC(=S)N.Cl[Cu]Cl |